Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round-up of the news in brief

HCPs need more education on TB 
Education for Health has launched a distance learning programme for TB aimed at healthcare professionals (HCPs) in the UK. The purpose of the training module is to increase awareness among HCPs of the symptoms of TB to aid a more speedy diagnosis. The learning outcomes of the course, which comprises online content and comprehensive written materials, include being able to analyse the prevalence and causes of TB and evaluate preventative measures, assess the impact of TB on the respiratory tract, select methods for diagnosis and analyse factors in good nursing care.

With the number of TB cases in England, Wales and Northern Ireland rising 10.8 per cent to 8,113 in 2005, and the figures for the number of deaths caused by the infection in Europe reaching 73,000 each year, swift diagnosis and treatment are crucial. For more information on the training module, visit www.educationforhealth.org.uk or call 01926 493313.

Two become one 
Bell Pottinger has merged healthcare agencies De Facto Communications and Ozone. The new 25-strong agency, trading as De Facto Communications, will be headed up by De Facto CEO Richard Anderson, with Ozone chairman Gareth Zundel taking up a full-time consultancy role at Bell Pottinger. Zundel with focus on finding growth and new business opportunities for Bell Pottinger in healthcare with a public sector focus.

PILs for the visually impaired 
The Royal National Institute for the Blind (RNIB) and Datapharm Communications have joined forces to provide a new service that will enable pharma companies to produce patient information leaflets (PILs) in large print and other formats. Pharma companies are required by new EC regulations to provide PILs in formats suitable for people with visual impairment. Through the RNIB Medicines Information Line (0800 198 5000), healthcare professionals and patients can receive new physical format PILs in large print, Braille and on audio CD; a PIL can also be listened to through the Medicines Information Line. Online at www.xpil.medicines.org.uk healthcare professionals and patients can receive electronic format PILs in large text (18-22 point) and a version that can used by a screen reader.

The Royal Pharmaceutical Society of Great Britain, the National Pharmacy Association and Ask About Medicines have supported the launch.

Double winner 
Red Door Communications was the proud winner of one of the two coveted healthcare awards at this yearís PR Week Awards, taking home OTC/Consumer category for its Gife of Life campaign on behalf of the Department of Health collaboration with UK Transplant and Astellas, Novartis and Roche. The winner of the Ethical healthcare category was Euro RSCG Biss Lancaster for the Levitra Global PR campaign for Bayer Healthcare. Highly commended agencies in the category were The Red Consultancy for the Secrets of Modern Motherhood for Scheringís Mirena and hsdcommunications for the Primary Care Dermatology Society.

Life through art 
Top prize at the 2006 Lilly Oncology on Canvas International Art Competition and Exhibition has been awarded to mother of three Linda Dibblee from Illinois, US for her bold and inspiring acrylic entitled Hair Again, a composition which captures the end of her treatment and ëthe hope and joy that followsí. Second place was awarded to Bobbie Redemer from Berkshire for her acrylic entitled Contemplation, which illustrates how she ëbegan absorbing the shock and then going through the feelings of bewilderment and fear of the unknowní. Third place was awarded to Consuelo Ardila Orjuela from Bogot·, Columbia. This year there were 2,000 entries from 43 countries.

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics